These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


181 related items for PubMed ID: 9210747

  • 1. Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter study.
    Amsterdam JD, Fawcett J, Quitkin FM, Reimherr FW, Rosenbaum JF, Michelson D, Hornig-Rohan M, Beasley CM.
    Am J Psychiatry; 1997 Jul; 154(7):963-9. PubMed ID: 9210747
    [Abstract] [Full Text] [Related]

  • 2. Are fluoxetine plasma levels related to outcome in obsessive-compulsive disorder?
    Koran LM, Cain JW, Dominguez RA, Rush AJ, Thiemann S.
    Am J Psychiatry; 1996 Nov; 153(11):1450-4. PubMed ID: 8890679
    [Abstract] [Full Text] [Related]

  • 3. Relationship between antidepressant response and plasma concentrations of fluoxetine and norfluoxetine.
    Norman TR, Gupta RK, Burrows GD, Parker G, Judd FK.
    Int Clin Psychopharmacol; 1993 Nov; 8(1):25-9. PubMed ID: 8473717
    [Abstract] [Full Text] [Related]

  • 4. Fluoxetine and norfluoxetine serum concentrations and clinical response in weekly versus daily dosing.
    Burke WJ, Hendricks SE, McArthur-Campbell D, Jacques D, Stull T.
    Psychopharmacol Bull; 1996 Nov; 32(1):27-32. PubMed ID: 8927671
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Serum fluoxetine and norfluoxetine concentrations and antidepressant response.
    Kelly MW, Perry PJ, Holstad SG, Garvey MJ.
    Ther Drug Monit; 1989 Nov; 11(2):165-70. PubMed ID: 2785723
    [Abstract] [Full Text] [Related]

  • 7. Fluoxetine: relationships among dose, response, adverse events, and plasma concentrations in the treatment of depression.
    Beasley CM, Bosomworth JC, Wernicke JF.
    Psychopharmacol Bull; 1990 Nov; 26(1):18-24. PubMed ID: 2196623
    [Abstract] [Full Text] [Related]

  • 8. Fluoxetine once every third day in the treatment of major depressive disorder.
    Tural U, Onder E.
    Eur Arch Psychiatry Clin Neurosci; 2003 Dec; 253(6):307-12. PubMed ID: 14714120
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Accumulation of fluoxetine and norfluoxetine in human brain during therapeutic administration.
    Renshaw PF, Guimaraes AR, Fava M, Rosenbaum JF, Pearlman JD, Flood JG, Puopolo PR, Clancy K, Gonzalez RG.
    Am J Psychiatry; 1992 Nov; 149(11):1592-4. PubMed ID: 1415832
    [Abstract] [Full Text] [Related]

  • 11. Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment.
    Brunswick DJ, Amsterdam JD, Fawcett J, Quitkin FM, Reimherr FW, Rosenbaum JF, Beasley CM.
    J Affect Disord; 2002 Apr; 68(2-3):243-9. PubMed ID: 12063152
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Plasma concentrations of the enantiomers of fluoxetine and norfluoxetine: sources of variability and preliminary observations on relations with clinical response.
    Jannuzzi G, Gatti G, Magni P, Spina E, Pacifici R, Zuccaro P, Torta R, Guarneri L, Perucca E.
    Ther Drug Monit; 2002 Oct; 24(5):616-27. PubMed ID: 12352933
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Poor response to fluoxetine: underlying depression, serotonergic overstimulation, or a "therapeutic window"?
    Cain JW.
    J Clin Psychiatry; 1992 Aug; 53(8):272-7. PubMed ID: 1500403
    [Abstract] [Full Text] [Related]

  • 16. Elevated cholesterol levels associated with nonresponse to fluoxetine treatment in major depressive disorder.
    Sonawalla SB, Papakostas GI, Petersen TJ, Yeung AS, Smith MM, Sickinger AH, Gordon J, Israel JA, Tedlow JR, Lamon-Fava S, Fava M.
    Psychosomatics; 2002 Aug; 43(4):310-6. PubMed ID: 12189257
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feeding.
    Kim J, Riggs KW, Misri S, Kent N, Oberlander TF, Grunau RE, Fitzgerald C, Rurak DW.
    Br J Clin Pharmacol; 2006 Feb; 61(2):155-63. PubMed ID: 16433870
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.